Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-12

Clinical Trial Update: Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous Lesions [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating molecular-targeted therapy using zinc finger nuclease for HPV-related cervical precancerous lesions. The study status is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zinc Finger Nuclease (zinc finger nuclease)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Human Papillomavirus-Related Malignant Neoplasm | Phase 1 | Status: UNKNOWN